SARS-CoV-2 Spike S1 Antikörper
-
- Target Alle SARS-CoV-2 Spike S1 Antikörper anzeigen
- SARS-CoV-2 Spike S1
-
Reaktivität
- SARS Coronavirus-2 (SARS-CoV-2)
-
Wirt
-
Human
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser SARS-CoV-2 Spike S1 Antikörper ist unkonjugiert
-
Applikation
- ELISA
- Verwendungszweck
- Anti-SARS-CoV-2 Spike S1 Protein Azide Free Clone CR3022 (IgA)
- Spezifität
- S1 domain of the SARS-CoV Spike protein (aa318-510) as well as SARS-CoV-2 (COVID-19) Spike protein
- Immunogen
- Recombinant antibody from a phage display library,Generated by sequencing peripheral blood lymphocytes of a patient exposed to the SARS-CoV.
- Klon
- CR3022-IgA
- Isotyp
- IgA kappa
- Top Product
- Discover our top product SARS-CoV-2 Spike S1 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
- Konservierungsmittel
- Without preservative
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Stable at +2-8°C for 12 months.
-
- Target
- SARS-CoV-2 Spike S1
- Abstract
- SARS-CoV-2 Spike S1 Produkte
- Synonyme
- E2 antikoerper, Surface Glycoprotein antikoerper, S antikoerper
- Hintergrund
- Receptor binding domain Spike protein / RBD spike protein
-